StockWatch
·
Pharmacy Retail
Shareholding13 Jul 2026, 07:41 pm

Srinidhi Fine-Chemicals LLP & Narahari Belide Increase Stake in Novelix Pharma

AI Summary

Srinidhi Fine-Chemicals LLP and Narahari Belide have disclosed an increase in their shareholding in Novelix Pharmaceuticals Ltd following the conversion of warrants into equity shares. The transaction, which occurred on July 9, 2026, was executed via preferential allotment. Post-acquisition, Srinidhi Fine-Chemicals LLP holds 10,002,000 shares (35.13% voting rights), and Narahari Belide holds 1,200,000 shares (4.21% voting rights). The total diluted share capital of Novelix Pharmaceuticals Ltd after the acquisition stands at Rs. 28,47,00,000, comprising 28,470,000 equity shares of Rs. 10 each.

Key Highlights

  • Srinidhi Fine-Chemicals LLP and Narahari Belide acquired shares via warrant conversion.
  • Acquisition was through preferential allotment on July 9, 2026.
  • Post-acquisition, combined shareholding is significant.
  • Disclosure made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
  • Total diluted share capital increased post-transaction.